CIK 0001658551 · Non-accelerated filer<br>Smaller reporting company
Amylyx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMLX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464600503
- Phone
- 617-682-0917
- Business address
- 55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
- 4 Open-market sale Co-Chief Executive Officer sold 21,490 shares at $3.47 ($74,482)
- 4 Open-market sale Co-Chief Executive Officer sold 21,490 shares at $3.46 ($74,454)
- 4 Open-market buy Director bought 10,000 shares at $3.70 ($37,005)
- 4 Grant or award Chief Legal Officer acquired 63,851 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 68,420 shares (grant or award)
- 4 Grant or award Co-Chief Executive Officer acquired 180,118 shares (grant or award)
- 4 Grant or award Co-Chief Executive Officer acquired 180,118 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 68,420 shares (grant or award)
- 4 Open-market sale Co-Chief Executive Officer sold 4,595 shares at $3.15 ($14,483)
- 4 Open-market sale Co-Chief Executive Officer sold 4,595 shares at $3.17 ($14,549)
- 4 Open-market sale Chief Legal Officer sold 1,611 shares at $3.12 ($5,022)
- 4 Open-market sale Chief Legal Officer sold 4,169 shares at $3.15 ($13,145)
- 4 Option exercise Co-Chief Executive Officer acquired 36,310 shares (option exercise)
- 4 Open-market sale Chief Legal Officer sold 3,678 shares at $3.49 ($12,839)
- 4 Open-market sale Co-Chief Executive Officer sold 11,851 shares at $3.47 ($41,108)
- 4 Open-market sale Co-Chief Executive Officer sold 11,855 shares at $3.47 ($41,104)
- 4 Gift Director gave 27,910 shares (gift)
- 4 Open-market sale Co-Chief Executive Officer sold 7,471 shares at $4.04 ($30,202)
- 4 Open-market sale Co-Chief Executive Officer sold 7,471 shares at $4.05 ($30,232)
- 4 Open-market sale Chief Medical Officer sold 5,421 shares at $5.54 ($30,007)
Page 4 of 11 · 207 filings